Add to ORKGLa décompensation de l’insuffisance cardiaque est une exacerbation aiguë d’une insuffisance cardiaque déjà existante et est aujourd’hui la première cause d’hospitalisation chez les patients âgés de plus de 65 ans. Les traitements actuels visent à améliorer les symptômes de la décompensation, néanmoins ceux-ci n’améliorent pas le devenir des patients après l’hospitalisation et ne diminue pas la dégradation progressive de la fonction cardiaque.Decompensation of heart failure is an acute exacerbation of an already existing heart failure and is the first cause of hospitalization in patients over 65 years old. Current treatments aim to improve the symptoms of decompensation; however, they do not improve the outcome of post-hospitalization and do...
Aims Treatment with sodium-glucose co-transporter 2 (SGLT2) inhibitors improves outcomes in patients...
AbstractForty years ago therapy for congestive heart failure was limited largely to the mercurial di...
Heart failure (HF) is common and associated with a poor prognosis, despite advances in treatment. Ov...
International audienceAims: Heart failure (HF) is the most frequent cause of hospital admission amon...
Prevalence of heart failure is increasing worldwide mainly due to the ageing of the population and t...
Heart failure with preserved ejection fraction (HFpEF) is a common and difficult-to-treat heart dise...
none12noAcutely decompensated heart failure (ADHF) represents the leading reason for hospital admiss...
International audienceHeart failure is the most common cardiovascular reason for hospital admission ...
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued ...
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued ...
The cardiovascular diseases are one of the main causes of mortality in the countries of Europe and N...
Domingo A Pascual-Figal, Francisco Pastor-Perez, Luis Caballero, Iris P Garrido, Maria Teresa Perez-...
(1) Background: Sodium-glucose co-transporter-2 (SGLT-2) inhibitors constitute a novel drug class wi...
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued ...
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued ...
Aims Treatment with sodium-glucose co-transporter 2 (SGLT2) inhibitors improves outcomes in patients...
AbstractForty years ago therapy for congestive heart failure was limited largely to the mercurial di...
Heart failure (HF) is common and associated with a poor prognosis, despite advances in treatment. Ov...
International audienceAims: Heart failure (HF) is the most frequent cause of hospital admission amon...
Prevalence of heart failure is increasing worldwide mainly due to the ageing of the population and t...
Heart failure with preserved ejection fraction (HFpEF) is a common and difficult-to-treat heart dise...
none12noAcutely decompensated heart failure (ADHF) represents the leading reason for hospital admiss...
International audienceHeart failure is the most common cardiovascular reason for hospital admission ...
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued ...
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued ...
The cardiovascular diseases are one of the main causes of mortality in the countries of Europe and N...
Domingo A Pascual-Figal, Francisco Pastor-Perez, Luis Caballero, Iris P Garrido, Maria Teresa Perez-...
(1) Background: Sodium-glucose co-transporter-2 (SGLT-2) inhibitors constitute a novel drug class wi...
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued ...
The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has recently issued ...
Aims Treatment with sodium-glucose co-transporter 2 (SGLT2) inhibitors improves outcomes in patients...
AbstractForty years ago therapy for congestive heart failure was limited largely to the mercurial di...
Heart failure (HF) is common and associated with a poor prognosis, despite advances in treatment. Ov...